UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

Theranostics, 2016, Vol.6 (2), p.262-271

2016

Volltextzugriff (PDF)

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4339-4348

2006

Volltextzugriff (PDF)

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111 In-ABY-025 Affibody Molecule

Journal of Nuclear Medicine, 2014-05, Vol.55 (5), p.730-735

2014

Volltextzugriff (PDF)

Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors

Tumor biology, 2012-06, Vol.33 (3), p.653-659

Carlsson, Jörgen

2012

Volltextzugriff (PDF)

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

The Journal of nuclear medicine (1978), 2016-06, Vol.57 (6), p.867

2016

Volltextzugriff (PDF)

Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (8), p.1337-1346

2017

Volltextzugriff (PDF)

High temperature corrosion in a 65 MW waste to energy plant

Fuel processing technology, 2007-12, Vol.88 (11-12), p.1178-1182

2007

Volltextzugriff (PDF)

EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides

Radiology and oncology, 2015-03, Vol.49 (1), p.50-58

2015

Volltextzugriff (PDF)

Analysis of radiation effects in two irradiated tumor spheroid models

Oncology letters, 2018-03, Vol.15 (3), p.3008-3016

2018

Volltextzugriff (PDF)

Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging

American journal of nuclear medicine and molecular imaging, 2016-01, Vol.6 (2), p.135-153

2016

Volltextzugriff (PDF)

[177Lu]Pertuzumab : Experimental therapy of HER-2-expressing xenografts

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.326-331

2007

Volltextzugriff (PDF)

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line

Biochemical and biophysical research communications, 2008-12, Vol.377 (2), p.489-494

2008

Volltextzugriff (PDF)

Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors

The Journal of nuclear medicine (1978), 2006-03, Vol.47 (3), p.512-519

2006

Volltextzugriff (PDF)

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases

International journal of oncology, 2007-09, Vol.31 (3), p.493-499

2007

Volltextzugriff (PDF)

HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides

Tumor biology, 2014-07, Vol.35 (7), p.6319-6326

2014

Volltextzugriff (PDF)

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Nuclear medicine and biology, 2007-08, Vol.34 (6), p.609-618

2007

Volltextzugriff (PDF)

Nuclisome: a novel concept for radionuclide therapy using targeting liposomes

European journal of nuclear medicine and molecular imaging, 2010, Vol.37 (1), p.114-123

2010

Volltextzugriff (PDF)

Engineering and characterization of a bispecific HER2 × EGFR-binding affibody molecule

Biotechnology and applied biochemistry, 2009-10, Vol.54 (2), p.121-131

2009

Volltextzugriff (PDF)

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule

Biotechnology and applied biochemistry, 2009-10, Vol.54 (2), p.121-131

2009

Volltextzugriff (PDF)

Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects

International journal of oncology, 2010-04, Vol.36 (4), p.757-763

2010

Volltextzugriff (PDF)

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

European journal of nuclear medicine and molecular imaging, 2006-06, Vol.33 (6), p.631-638

2006

Volltextzugriff (PDF)

Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden

Journal of neuro-oncology, 2003-03, Vol.62 (1-2), p.135-144

2003

Volltextzugriff (PDF)

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

FEBS letters, 2010-06, Vol.584 (12), p.2670-2680

2010

Volltextzugriff (PDF)

Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2006-10, Vol.33 (10), p.1185-1195

2006

Volltextzugriff (PDF)

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2773-2782

2007

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(292)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(195)
Life Sciences & Biomedicine
(177)
Humans
(165)
Biological And Medical Sciences
(99)
Oncology
(89)
Medical Sciences
(85)
Medicine
(68)
Medicin
(67)
Animals
(65)
Tumors
(51)
Female
(46)
Medicin Och Hälsovetenskap
(44)
Male
(42)
Radiology, Nuclear Medicine & Medical Imaging
(35)
Middle Aged
(34)
Cell Line, Tumor
(27)
Physical Sciences
(27)
Tumor Cells, Cultured
(26)
Adult
(25)
Mice
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111 In-ABY-025 Affibody Molecule

Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients

Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

High temperature corrosion in a 65 MW waste to energy plant

EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides

Analysis of radiation effects in two irradiated tumor spheroid models

Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging

[177Lu]Pertuzumab : Experimental therapy of HER-2-expressing xenografts

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line

Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases

HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Nuclisome: a novel concept for radionuclide therapy using targeting liposomes

Engineering and characterization of a bispecific HER2 × EGFR-binding affibody molecule

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule

Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule

Suchergebnisse filtern